Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bickle

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|February 21, 2019
The Academic Pill: How Academia Contributes to Curing DiseasesMarc Bickle
Analytical and Bioanalytical Chemistry|June 26, 2010
The beautiful cell: high-content screening in drug discoveryMarc Bickle
Combinatorial Chemistry & High Throughput Screening|March 26, 2014
The technology development studio of the MPI-CBG: an open access cell-based screening facilityMarc Bickle
Idrugs : the Investigational Drugs Journal|November 7, 2008
High-content screening: a new primary screening tool?Marc Bickle
Expert Opinion on Drug Discovery|July 26, 2012
Systems drug discovery: a quantitative, objective approach for safer drug developmentMarc Bickle
Journal of Biomolecular Screening|September 22, 2016
SLAS Europe High-Content Screening Conference in Dresden: A Glimpse of the Future?Maria Montoya, Thierry Dorval, Marc Bickle
SLAS Discovery : Advancing Life Sciences R & D|January 9, 2019
Unbiased Phenotype Detection Using Negative ControlsAntje Janosch, Carolin Kaffka, Marc Bickle
Methods in Molecular Biology (Clifton, N.J.)|October 31, 2017
Live-Cell High Content Screening in Drug DevelopmentMilan Esner, Felix Meyenhofer, Marc Bickle
Journal of Biomolecular Screening|August 21, 2015
The King Is Dead, Long Live the King! JBS Special Issue on Screening by RNAi and Precise Genome Editing TechnologiesMarc Bickle, Hakim Djaballah, Lorenz Martin Mayr
Current Neurology and Neuroscience Reports|February 11, 2019
Unbiased Screens for Modifiers of Alpha-Synuclein ToxicityMatthias Höllerhage, Marc Bickle, Günter U Höglinger
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
SLAS Discovery : Advancing Life Sciences R & D|February 21, 2019
The Academic Pill: How Academia Contributes to Curing DiseasesMarc Bickle
Analytical and Bioanalytical Chemistry|June 26, 2010
The beautiful cell: high-content screening in drug discoveryMarc Bickle
Combinatorial Chemistry & High Throughput Screening|March 26, 2014
The technology development studio of the MPI-CBG: an open access cell-based screening facilityMarc Bickle
Idrugs : the Investigational Drugs Journal|November 7, 2008
High-content screening: a new primary screening tool?Marc Bickle
Expert Opinion on Drug Discovery|July 26, 2012
Systems drug discovery: a quantitative, objective approach for safer drug developmentMarc Bickle
Journal of Biomolecular Screening|September 22, 2016
SLAS Europe High-Content Screening Conference in Dresden: A Glimpse of the Future?Maria Montoya, Thierry Dorval, Marc Bickle
SLAS Discovery : Advancing Life Sciences R & D|January 9, 2019
Unbiased Phenotype Detection Using Negative ControlsAntje Janosch, Carolin Kaffka, Marc Bickle
Methods in Molecular Biology (Clifton, N.J.)|October 31, 2017
Live-Cell High Content Screening in Drug DevelopmentMilan Esner, Felix Meyenhofer, Marc Bickle
Journal of Biomolecular Screening|August 21, 2015
The King Is Dead, Long Live the King! JBS Special Issue on Screening by RNAi and Precise Genome Editing TechnologiesMarc Bickle, Hakim Djaballah, Lorenz Martin Mayr
Current Neurology and Neuroscience Reports|February 11, 2019
Unbiased Screens for Modifiers of Alpha-Synuclein ToxicityMatthias Höllerhage, Marc Bickle, Günter U Höglinger
Pageof 7